A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment.
Identifieur interne : 004697 ( PubMed/Curation ); précédent : 004696; suivant : 004698A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment.
Auteurs : G M Petzinger [États-Unis] ; S B BressmanSource :
- Movement disorders : official journal of the Movement Disorder Society [ 0885-3185 ] ; 1997.
English descriptors
- KwdEn :
- Adult, Anti-Dyskinesia Agents (administration & dosage), Anti-Dyskinesia Agents (adverse effects), Depressive Disorder (drug therapy), Depressive Disorder (psychology), Dyskinesia, Drug-Induced (drug therapy), Dyskinesia, Drug-Induced (etiology), Female, Humans, Neuroleptic Malignant Syndrome (diagnosis), Neuroleptic Malignant Syndrome (etiology), Neurologic Examination (drug effects), Tetrabenazine (administration & dosage), Tetrabenazine (adverse effects), Thiothixene (administration & dosage), Thiothixene (adverse effects).
- MESH :
- chemical , administration & dosage : Anti-Dyskinesia Agents, Tetrabenazine, Thiothixene.
- chemical , adverse effects : Anti-Dyskinesia Agents, Tetrabenazine, Thiothixene.
- diagnosis : Neuroleptic Malignant Syndrome.
- drug effects : Neurologic Examination.
- drug therapy : Depressive Disorder, Dyskinesia, Drug-Induced.
- etiology : Dyskinesia, Drug-Induced, Neuroleptic Malignant Syndrome.
- psychology : Depressive Disorder.
- Adult, Female, Humans.
DOI: 10.1002/mds.870120219
PubMed: 9087987
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :004697
Links to Exploration step
pubmed:9087987Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment.</title>
<author><name sortKey="Petzinger, G M" sort="Petzinger, G M" uniqKey="Petzinger G" first="G M" last="Petzinger">G M Petzinger</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, Columbia-Presbyterian Medical Center, New York, New York, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Columbia-Presbyterian Medical Center, New York, New York</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bressman, S B" sort="Bressman, S B" uniqKey="Bressman S" first="S B" last="Bressman">S B Bressman</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1997">1997</date>
<idno type="RBID">pubmed:9087987</idno>
<idno type="pmid">9087987</idno>
<idno type="doi">10.1002/mds.870120219</idno>
<idno type="wicri:Area/PubMed/Corpus">004697</idno>
<idno type="wicri:Area/PubMed/Curation">004697</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment.</title>
<author><name sortKey="Petzinger, G M" sort="Petzinger, G M" uniqKey="Petzinger G" first="G M" last="Petzinger">G M Petzinger</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, Columbia-Presbyterian Medical Center, New York, New York, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Neurology, Columbia-Presbyterian Medical Center, New York, New York</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bressman, S B" sort="Bressman, S B" uniqKey="Bressman S" first="S B" last="Bressman">S B Bressman</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1997" type="published">1997</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Anti-Dyskinesia Agents (administration & dosage)</term>
<term>Anti-Dyskinesia Agents (adverse effects)</term>
<term>Depressive Disorder (drug therapy)</term>
<term>Depressive Disorder (psychology)</term>
<term>Dyskinesia, Drug-Induced (drug therapy)</term>
<term>Dyskinesia, Drug-Induced (etiology)</term>
<term>Female</term>
<term>Humans</term>
<term>Neuroleptic Malignant Syndrome (diagnosis)</term>
<term>Neuroleptic Malignant Syndrome (etiology)</term>
<term>Neurologic Examination (drug effects)</term>
<term>Tetrabenazine (administration & dosage)</term>
<term>Tetrabenazine (adverse effects)</term>
<term>Thiothixene (administration & dosage)</term>
<term>Thiothixene (adverse effects)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anti-Dyskinesia Agents</term>
<term>Tetrabenazine</term>
<term>Thiothixene</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Anti-Dyskinesia Agents</term>
<term>Tetrabenazine</term>
<term>Thiothixene</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Neuroleptic Malignant Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Neurologic Examination</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Depressive Disorder</term>
<term>Dyskinesia, Drug-Induced</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
<term>Neuroleptic Malignant Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Depressive Disorder</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Female</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">9087987</PMID>
<DateCreated><Year>1997</Year>
<Month>07</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted><Year>1997</Year>
<Month>07</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0885-3185</ISSN>
<JournalIssue CitedMedium="Print"><Volume>12</Volume>
<Issue>2</Issue>
<PubDate><Year>1997</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment.</ArticleTitle>
<Pagination><MedlinePgn>246-8</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Petzinger</LastName>
<ForeName>G M</ForeName>
<Initials>GM</Initials>
<AffiliationInfo><Affiliation>Department of Neurology, Columbia-Presbyterian Medical Center, New York, New York, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bressman</LastName>
<ForeName>S B</ForeName>
<Initials>SB</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>UNITED STATES</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018726">Anti-Dyskinesia Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>7318FJ13YJ</RegistryNumber>
<NameOfSubstance UI="D013888">Thiothixene</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>Z9O08YRN8O</RegistryNumber>
<NameOfSubstance UI="D013747">Tetrabenazine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000328">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D018726">Anti-Dyskinesia Agents</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D003866">Depressive Disorder</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000523">psychology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004409">Dyskinesia, Drug-Induced</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009459">Neuroleptic Malignant Syndrome</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000209">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D009460">Neurologic Examination</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D013747">Tetrabenazine</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D013888">Thiothixene</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName>
<QualifierName MajorTopicYN="Y" UI="Q000009">adverse effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1997</Year>
<Month>3</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1997</Year>
<Month>3</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1997</Year>
<Month>3</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">9087987</ArticleId>
<ArticleId IdType="doi">10.1002/mds.870120219</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004697 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 004697 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:9087987 |texte= A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:9087987" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a MovDisordV3
![]() | This area was generated with Dilib version V0.6.23. | ![]() |